Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 25
2003 17
2004 17
2005 19
2006 40
2007 46
2008 43
2009 36
2010 33
2011 51
2012 43
2013 55
2014 58
2015 52
2016 50
2017 41
2018 33
2019 38
2020 36
2021 35
2022 40
2023 44
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

713 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma.
Teishima J, Hara T, Tobe T, Hirata J, Ueki H, Wakita N, Shiraishi Y, Okamura Y, Bando Y, Terakawa T, Furukawa J, Harada KI, Nakano Y, Fujisawa M. Teishima J, et al. Among authors: fujisawa m. Can Urol Assoc J. 2024 Jan 30. doi: 10.5489/cuaj.8548. Online ahead of print. Can Urol Assoc J. 2024. PMID: 38319607 Free article.
The harmful effects of overlooking acute bacterial prostatitis.
Yang Y, Shigemura K, Maeda K, Moriwaki M, Chen KC, Nakano Y, Fujisawa M. Yang Y, et al. Among authors: fujisawa m. Int J Urol. 2024 Jan 18. doi: 10.1111/iju.15390. Online ahead of print. Int J Urol. 2024. PMID: 38239011 Review.
Cine magnetic resonance imaging predicts thrombus adhesion in metastatic renal cell carcinoma with an inferior vena cava tumor thrombus: A case of pathological complete response with pembrolizumab plus lenvatinib.
Hara T, Furukawa J, Tsutiya T, Kodama T, Uehara K, Terakawa T, Harada K, Teishima J, Nakano Y, Fujisawa M. Hara T, et al. Among authors: fujisawa m. IJU Case Rep. 2023 Nov 8;7(1):60-63. doi: 10.1002/iju5.12668. eCollection 2024 Jan. IJU Case Rep. 2023. PMID: 38173458 Free PMC article.
713 results